幹細胞治療市場：按細胞來源、按應用、按最終用戶、按地區

Stem Cell Therapy Market, By Cell Source, By Application, By End User, By Geography

出版日期: 2024年05月23日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

奈米農藥市場估計2024年為7.6億美元，預計2031年將達到17.9億美元，2024年至2031年年複合成長率（CAGR）預計為13%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	7.6億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測2024-2031年年複合成長率：	13.00%	2031年價值預測	17.9億美元

圖：2024年依地區分類的奈米農藥市場佔有率（%）

奈米農藥是一種將奈米技術融入傳統殺蟲劑中以提高其效力和功效的製劑。透過將農藥活性成分的粒徑減小到奈米範圍，表面積增加，可以更有效地控制害蟲。奈米農藥有助於降低散佈量並降低對非目標生物體的毒性。這使得農藥能夠精確且受控地僅輸送到入侵和感染所需的區域。隨著人們對殘留管理和環境安全的日益關注，奈米農藥成為現代農業的永續解決方案。

市場動態：

奈米農藥市場的驅動力是提高農業生產力，同時最大限度地減少環境污染的需求。人們對奈米配方的日益偏好推動了需求的成長，這種配方可以在減少農藥使用的情況下提高作物產量。限制有毒農藥的嚴格法規以及農藥靶向奈米載體的開發也推動了農藥的採用。然而，開發新的奈米農藥產品包括高昂的研發成本和不確定的長期影響，阻礙了更廣泛的商業化。使用生物分解性聚合物的生物農藥的奈米尺寸不斷增加，為解決這些問題提供了機會。依賴奈米農藥的精密農業技術的普及可能會進一步推動市場成長。

本研究的主要特點

本報告詳細分析了全球奈米農藥市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球奈米農藥市場的主要企業。
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 15.15 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	22.60%	2031 Value Projection:	US$ 63.23 Bn

Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.

Market Dynamics:

Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.

Key Features of the Study:

This report provides an in-depth analysis of the global stem cell therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.

Detailed Segmentation-

By Cell Source:
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Others
By Application:
- Musculoskeletal Disorders
- Wounds and Injuries
- Cancer
- Autoimmune Disorders
- Others
By End User:
- Hospitals
- Cell Banks
- Academic and Research Institutes
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Osiris Therapeutics, Inc.
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Anterogen Co. Ltd.
- Pharmicell Co., Inc.
- Stemedica Cell Technologies, Inc.
- Magellan
- Medipost Co., Ltd
- Athersys Inc.
- Biorestorative Therapies Inc.
- Brainstorm Cell Limited.
- ViaCyte Inc.
- Cellular Biomedicine Group
- C.O., LTD.
- NuVasive Inc.
- RTI Surgical
- AlloSource

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cell Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Stem Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Stem Cell Therapy Market, By Cell Source, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Adult Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Induced Pluripotent Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Embryonic Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Stem Cell Therapy Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Wounds and Injuries
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Stem Cell Therapy Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Banks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Stem Cell Therapy Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Osiris Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Kolon TissueGene, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JCR Pharmaceuticals Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Anterogen Co. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pharmicell Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stemedica Cell Technologies, Inc.
- Magellan
- Medipost Co., Ltd
- Athersys Inc.
- Biorestorative Therapies Inc.
- Brainstorm Cell Limited.
- ViaCyte Inc.
- Cellular Biomedicine Group
- ANTEROGEN. C.O., LTD.
- NuVasive Inc.
- RTI Surgical
- AlloSource